Purchase Order HT001422P0007
- Not listed
- This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The $99,326.94 contract is for the supply of radiopharmaceuticals to support nuclear medicine diagnostic imaging and treatment procedures for veterans and military personnel. The award has no set-aside designation, though Jubilant Radiopharma is a self-certified small disadvantaged business. Jubilant Radiopharma holds...
- This is a firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The contract, with a ceiling value of $88,977.92, is for the delivery of radiopharmaceuticals to support nuclear medicine procedures, PET scans, cardiac imaging, and cancer treatment diagnostics at VA medical facilities. Jubilant Radiopharma is a subsidiary of...
- This federal contract award is for the delivery of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA) by Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The $752,325.70 firm-fixed-price delivery order contract has an ultimate completion date of September 30, 2026. Jubilant Radiopharma, a for-profit, self-certified small disadvantaged business, will provide specialized medical isotopes and radiopharmaceuticals, such as Ga-68 Dotatate, iodine...
- This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a self-certified small disadvantaged business. The $85,588.19 contract is for the supply of radiopharmaceuticals to the VA's Veterans Integrated Service Network 12. The contract has an ultimate completion date of March 31, 2022 and is not set aside. Jubilant Radiopharma is a subsidiary of Jubilant Life Sciences Limited...
- This is a federal contract award to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business that specializes in manufacturing and supplying radiopharmaceuticals and nuclear medicine products. The contract, valued at $122,387.32, is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) for the provision of radiopharmaceuticals such as Ga-68 Dotatate, iodine I-123, technetium-99m, and other specialized medical...
- The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract worth $885,233.80 to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The contract is for the delivery of radiopharmaceuticals, including Ga-68 Dotatate, iodine I-123, technetium-99m, and other specialized medical isotopes used in positron emission tomography (PET) scans, cardiac imaging, and cancer treatment diagnostics. This contract supports nuclear medicine...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $93,446.62 firm fixed-price delivery order contract to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business. This contract is to provide radiopharmaceuticals supporting nuclear medicine services and procedures for veterans at VA medical facilities. Jubilant Radiopharma has held multiple indefinite delivery contracts and blanket purchase...
- This firm-fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The $130,354.94 contract is for the delivery of nuclear medicine radiopharmaceuticals, such as Ga-68 Dotatate, iodine I-123, and technetium-99m, to support diagnostic imaging and cancer treatment procedures for veterans at VA medical facilities. Jubilant Radiopharma holds...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for the provision of radiopharmaceutical products and services from October 1, 2019 to March 31, 2020. The potential value of this award is $128,439.35. Jubilant Radiopharma is a self-certified small disadvantaged business that has received multiple contract vehicles from the VA and Defense Health Agency...
- This contract award is for the supply of nuclear medicine radiopharmaceuticals to the Department of Veterans Affairs (VA). The prime contractor is Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. This award has a ceiling value of $73,037 and is a firm-fixed-price delivery order contract. Jubilant Radiopharma provides a variety of essential medical isotopes and radiopharmaceuticals used in diagnostic imaging and cancer...
The Defense Health Agency awarded a $258,331 firm fixed-price purchase order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on October 22, 2021, for the supply of Mertiatide MAG3 compounded I-131 capsules and related short-lived molecular imaging agents for injection and oral radioactive therapeutics. These products support nuclear medicine diagnostic and therapeutic procedures across federal healthcare facilities. The contract was completed by October 22, 2025, with no set-aside designation applied. Jubilant Radiopharma, a small disadvantaged business and subsidiary of Jubilant Life Sciences Limited, specializes in manufacturing and distributing radiopharmaceuticals and nuclear medicine products to federal healthcare agencies, with performance taking place in Bethesda, Maryland. Jubilant Radiopharma maintains an extensive portfolio of federal contracts, primarily serving the Department of Veterans Affairs through multiple Indefinite Delivery Vehicles with potential values ranging from $420,000 to $39.8 million, in addition to contracts with the Defense Health Agency such as this award. The company's radiopharmaceutical product range includes Gallium 68 Dotatate, iodine I-123, technetium-99m, and other specialized nuclear medicine isotopes used for diagnostic imaging, positron emission tomography scans, cardiac imaging, and cancer treatment diagnostics. Through its established relationships with various Veterans Integrated Service Networks and federal healthcare organizations, Jubilant Radiopharma has demonstrated consistent capability in supplying critical medical isotopes essential to nuclear medicine services across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00012 | Exercise an Option | $0 | 10/16/25 | |
| P00011 | Other Administrative Action | $51.7k | 10/28/24 | |
| P00010 | Exercise an Option | $0 | 10/21/24 | |
| P00009 | Other Administrative Action | $0 | 6/6/24 | |
| P00008 | Funding Only Action | $51.7k | 10/30/23 |